Therapeutic application of regeneration-associated cells: a novel
Chronic diseases with comorbidities or associated risk factors may impair the function of regenerative cells and the regenerative microenvironment. Following this consideration, the vasculogenic conditioning culture (VCC) method was developed to boost the regenerative microenvironment to achieve regeneration-associated cells (RACs), which contain vasculogenic endothelial progenitor cells (EPCs) and anti-inflammatory/anti-immunity cells. Preclinical and clinical studies demonstrate that RAC transplantation is a safe and convenient cell population for promoting ischemic tissue recovery based on its strong vasculogenicity and functionality. The outputs of the scientific reports reviewed in the present study shed light on the fact that RAC transplantation is efficient in curing various diseases. Here, we compactly highlight the universal features of RACs and the latest progress in their translation toward clinics.
Monocyte and macrophage heterogeneity in the heart. - Abstract
Monocyte and macrophage heterogeneity in the heart. - Abstract
Vasculogenic Conditioning of Peripheral Blood Mononuclear Cells
Summary of our study.
PDF) Contemporary Challenges of Regenerative Therapy in Patients
A comparison between immunoregulatory functions of mesenchymal
Human stem cell sources and subtypes.
Therapeutic application of regeneration-associated cells: a novel
Histologic analysis of the submandibular glands at 12 weeks after
Post-QQc diabetic progenitor cell therapy enhances wound
Adult Stem Cell Therapy for Stroke: Challenges and Progress
